Journal of Vascular Research · 2006 · 23 citations · 39 references
Life SciencesEndocrinologyPhysiologyCell SignalingReproductive PhysiologySignal TransductionProlactin PhysiologyVascular DevelopmentProlactin Gene ExpressionProlactin Receptors
BACKGROUND: Controversial reports on prolactin receptors (PRL-R), the long and short form, on endothelial cells (EC) may be explained by the choice of EC derived from the micro- and macrovascular bed of either endocrine and non-endocrine organs. METHODS: We studied here PRL-R expression in organs [bovine corpus luteum (CL), umbilical vein, aorta] and in organ-derived EC cultures. RESULTS: In the intact CL, both PRL-R forms were present at mRNA and protein level throughout the oestrous cycle stages. The short form prevailed as protein. PRL-R-positive EC were noted by immunofluorescent staining in arterial blood vessels of CL septa, in the umbilical vein and the aorta. In EC cultures of micro- and macrovascular origin, transcripts of both PRL-R forms were shown; again the short-form protein prevailed. Blocking experiments with anti-prolactin (PRL) antibody led to a 60% decrease in cell growth. Treatment with PRL had no effect. CONCLUSION: PRL-R expression in micro- and macrovascular EC is associated with the predominant short form.
39
Identification of an angiogenic mitogen selective for endocrine gland endothelium
Jennifer LeCouter, Joe Kowalski, Jessica Foster et al. · Nature · 2001 · 555 citations
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
C Clapp, Joseph Martial, Raphael C. Guzman et al. · Endocrinology · 1993 · 326 citations
Medicine, Oncology, Pharmacology +13
Ingrid Struman, Frauke Bentzien, Hsinyu Lee et al. · Proceedings of the National Academy of Sciences · 1999 · 278 citations · Full text